EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 23-Jun-2026 04:16 ET (23-Jun-2026 08:16 GMT/UTC)

LLM treatment advice agrees with physician recommendations in early-stage HCC, but falls short in late stage

PLOS
Peer-Reviewed Publication

Large language models (LLM) can generate treatment recommendations for straightforward cases of hepatocellular carcinoma (HCC) that align with clinical guidelines but fall short in more complex cases, according to a new study by Ji Won Han from The Catholic University of Korea and colleagues publishing January 13^th in the open-access journal PLOS Medicine.

Journal: PLOS Medicine

Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the potential to overcome treatment resistance to anti-PD-1 immune checkpoint inhibitors in multiple cancer types.

Journal: Nature Medicine

Therapies that target specific type of cell death may be an effective avenue for cancer treatment, UTHealth Houston researchers find

University of Texas Health Science Center at Houston
Peer-Reviewed Publication

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth Houston.

Journal: Trends in Cancer

Genetic predisposition to excess body weight and survival in women diagnosed with breast cancer

JAMA Network
Peer-Reviewed Publication

About The Study: In this cohort of nonmetastatic breast cancer survivors, women who were genetically predisposed to having a higher body mass index were at increased risk of all-cause mortality. Targeted lifestyle recommendations to mitigate their genetic predisposition should be considered to lower this risk.

Journal: JAMA Network Open

New program at UT Health San Antonio delivers breakthrough care for limb loss patients

The University of Texas at San Antonio Health Science Center
Business Announcement

UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), proudly announces the launch of the Limb Optimization Program, a multidisciplinary initiative delivering advanced care for patients facing complex extremity deformity or dysfunction due to trauma, tumor, or congenital condition. Designed to improve identity, functional outcome, and quality of life for patients across the region, the program combines limb preservation, amputation care and reconstructive solutions such as osseointegration.

New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data shows

McMaster University
Peer-Reviewed Publication

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis — a dangerous, disease-induced build-up of scar tissue in the liver that often leads to cancer.

Journal: Cell Metabolism

New hypothesis links HPV E6 and SARS‑CoV‑2 spike proteins to reduced p53 activity

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – January 13, 2026 – A new hypothesis article was published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis: HPV E6 and COVID spike proteins cooperate in targeting tumor suppression by p53.”

Journal: Oncotarget

City of Hope experts available to provide insight on the American Cancer Society’s new ‘Cancer Statistics, 2026’ report

City of Hope
Reports and Proceedings

The American Cancer Society today released its annual “Cancer Statistics, 2026” and “Cancer Facts & Figures 2026” report — the first national snapshot of this year’s cancer trends. Experts from City of Hope^®, one of the country’s leading cancer research and treatment institutions, are available immediately for interviews to help interpret key trends and provide context for how these findings affect patients, families and the future of cancer care. We also have patients available for interviews.

Journal: CA A Cancer Journal for Clinicians

Rhythm contains important information for the cell

AMOLF
Peer-Reviewed Publication

AMOLF researchers discovered a mysterious interplay of insulin signals in the worm C. elegans. The insulin-driven protein DAF-16 does not only move in and out of the cell nucleus in a complex rhythm, it does so at exactly the same moment in all cells of the body. Because of the many similarities between C. elegans and humans, the research may contribute to a better understanding of diseases such as diabetes, cancer and ageing.

Journal: Nature Communications
Funder: Dutch Research Council

Caught in the act: Scientists observe infections by cancer-causing retroviruses in koalas as they occur

Leibniz Institute for Zoo and Wildlife Research (IZW)
Peer-Reviewed Publication

An international team of scientists analysed the ongoing colonization by two retroviruses of the germline of koalas and resulting deaths from cancer in multi-generational pedigrees of over 100 koalas in US and European Zoos. In the journal Nature Communications, they describe the genome sequencing of the koalas and their analysis of integration in or near genes involved in cancer, new germline integrations within a single generation, and deaths from cancer caused by the retroviral integration. Based on this work, the scientists calculated genetic risk scores (GRS) that can help guide koala breeding programs and thereby benefit koala conservation efforts.

Journal: Nature Communications